Cargando…
Glucocorticoid treatment of patients with SARS: implications for mechanisms of immunopathology
Autor principal: | Panesar, Nirmal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097456/ http://dx.doi.org/10.1038/nri1835-c1 |
Ejemplares similares
-
What caused lymphopenia in SARS and how reliable is the lymphokine status in glucocorticoid-treated patients?
por: Panesar, N.S.
Publicado: (2008) -
Lymphopenia in SARS
por: Panesar, Nirmal S
Publicado: (2003) -
COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options
por: van Eijk, Larissa E, et al.
Publicado: (2021) -
COVID-19: immunopathology and its implications for therapy
por: Cao, Xuetao
Publicado: (2020) -
Multiple sclerosis: Immunopathological heterogeneity and its implications
por: Engelhardt, Britta, et al.
Publicado: (2022)